Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$267K Sell
2,080
-92
-4% -$10.8K 0.24% 119
2026
Q1
$261K Buy
2,172
+145
+7% +$16.7K 0.26% 106
2025
Q4
$213K Sell
2,027
-390
-16% -$36.6K 0.22% 122
2025
Q3
$241K Buy
+2,417
New +$199K 0.35% 87

Other funds holding MRK

Invested Advisors's MRK Position: Q2 2026 in Review

Invested Advisors reduced its Merck (MRK) stake by 4.2% in Q2 2026, selling an estimated $10.8K and leaving 2,080 shares worth $267K. The position accounts for 0.24% of the portfolio, ranked #119.

Invested Advisors first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 3,849 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Invested Advisors held 2,080 shares of Merck worth $267K as of Q2 2026.
  • Invested Advisors sold 92 Merck shares in Q2 2026, an estimated $10.8K.
  • Merck made up 0.24% of Invested Advisors's portfolio in Q2 2026, its #119 holding.
  • Invested Advisors first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 3,849 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Invested Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.